findmyKOL
Clinical trialNCT04825288Active, not recruitingPhase 1/PHASE2Interventional

XB2001 in Combination With ONIVYDE + 5-FU/LV (+Folinic Acid) in Advanced Pancreatic Cancer

SponsorXBiotech, Inc.Enrollment76Pancreatic Cancer
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

28 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Arizona Oncology Associates

    Tucson, Arizona, United States

  • Disney Family Cancer Center at Providence St. Joseph Medical Center

    Burbank, California, United States

  • Toi Clinical Research

    Cerritos, California, United States

  • Providence St. Joseph Heritage - Fullerton, Ca

    Fullerton, California, United States

  • Hoag Memorial Hospital Presbyterian

    Newport Beach, California, United States

  • Grand Valley Oncology

    Grand Junction, Colorado, United States

  • Sarah Cannon - Florida Cancer Specialists

    Lake Mary, Florida, United States

  • Mt. Sinai Comprehensive Cancer Center

    Miami Beach, Florida, United States

  • Sarasota Memorial Hospital

    Sarasota, Florida, United States

  • Goshen Center for Cancer Care

    Goshen, Indiana, United States

  • Alliance for Multispecialty Research, Llc

    Merriam, Kansas, United States

  • Ochsner Clinic Foundation

    New Orleans, Louisiana, United States

  • Barbara Ann Karmanos Cancer Institute

    Detroit, Michigan, United States

  • Revive Research - Farmington Hills

    Farmington Hills, Michigan, United States

  • Revive Research - Sterling Heights

    Sterling Heights, Michigan, United States

  • St. Vincent Frontier Cancer Center

    Billings, Montana, United States

  • Summit Medical Group

    Florham Park, New Jersey, United States

  • Stony Brook Cancer Center

    Stony Brook, New York, United States

  • Montefiore Einstein Medical Center

    The Bronx, New York, United States

  • Providence Portland

    Portland, Oregon, United States

  • Upmc Hillman Cancer Center

    Pittsburgh, Pennsylvania, United States

  • University of Tennessee Medical Center Cancer Institute

    Knoxville, Tennessee, United States

  • Sarah Cannon - Tennessee Oncology

    Nashville, Tennessee, United States

  • Vanderbilt University

    Nashville, Tennessee, United States

  • Mary Crowley Cancer Research

    Dallas, Texas, United States

  • Community Cancer Trials of Utah

    Ogden, Utah, United States

  • Virginia Cancer Specialists

    Fairfax, Virginia, United States

  • Bon Secours St. Francis Cancer Center

    Midlothian, Virginia, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
27 May 2021
Primary completion
26 Oct 2023
Completion
10 Jun 2025
Last update posted
28 Feb 2025
Registered enrollment
76
Registry id
NCT04825288

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.